Wall Street Associates’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Wall Street Associates’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$341K	Hold	22,800	–	–	0.23%	157
2016 Q3	$286K	Hold	22,800	–	–	0.1%	196
2016 Q2	$205K	Hold	22,800	–	–	0.08%	211
2016 Q1	$226K	Hold	22,800	–	–	0.09%	213
2015 Q4	$262K	Hold	22,800	–	–	0.07%	283
2015 Q3	$308K	Sell	22,800 -237,300	-91%	-$3.22M	0.06%	291
2015 Q2	$3.6M	Sell	260,100 -9,000	-3%	-$122K	0.34%	103
2015 Q1	$3.79M	Buy	269,100 +46,700	+21%	+$636K	0.36%	96
2014 Q4	$3.03M	Sell	222,400 -8,800	-4%	-$120K	0.29%	107
2014 Q3	$3.53M	Sell	231,200 -22,000	-9%	-$337K	0.36%	101
2014 Q2	$4.26M	Buy	253,200 +44,600	+21%	+$803K	0.37%	101
2014 Q1	$4.19M	Buy	208,600 +30,600	+17%	+$662K	0.34%	103
2013 Q4	$3.45M	Buy	+178,000	New	+$3.15M	0.28%	121

Other funds holding OXFD

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $432M AUM 42.58% 1-Year Est. Return

Wall Street Associates's OXFD Position: Q4 2016 in Review

Wall Street Associates held its Oxford Immunotec Global PLC Ordinary Shares (OXFD) position steady in Q4 2016 at 22,800 shares worth $341K. The position accounts for 0.23% of the portfolio, ranked #157.

Wall Street Associates first reported a position in OXFD in Q4 2013 and has held it in 13 quarters since. The position peaked at $4.26M in Q2 2014. 73 funds tracked by Wall St. Rank hold OXFD as of Q4 2016.

Wall Street Associates held 22,800 shares of Oxford Immunotec Global PLC Ordinary Shares worth $341K as of Q4 2016.
Wall Street Associates left its Oxford Immunotec Global PLC Ordinary Shares share count unchanged in Q4 2016.
Oxford Immunotec Global PLC Ordinary Shares made up 0.23% of Wall Street Associates's portfolio in Q4 2016, its #157 holding.
Wall Street Associates first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2013 and has held it in 13 quarters since.
Wall Street Associates's Oxford Immunotec Global PLC Ordinary Shares position peaked at $4.26M in Q2 2014.
73 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q4 2016.

Based on Wall Street Associates's 13F filing for Q4 2016, filed 18 Jan 2017.